Regeneron Pharmaceuticals (REGN) reported a profit for first quarter that decreased from the same period last year and missed the Street estimates.
The company's earnings totaled $722 million, or $6.27 per share. This compares with $818 million, or $7.17 per share, in last year's first quarter.
Excluding items, Regeneron Pharmaceuticals reported adjusted earnings of $1.116 billion or $9.55 per share for the period.
Analysts on average had expected the company to earn $10.1 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter fell 0.5% to $3.145 billion from $3.162 billion last year.
Regeneron Pharmaceuticals earnings at a glance (GAAP) :
-Earnings (Q1): $722 Mln. vs. $818 Mln. last year.-EPS (Q1): $6.27 vs. $7.17 last year.-Revenue (Q1): $3.145 Bln vs. $3.162 Bln last year.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.